Vectus Biosystems Ltd (VBS) - Total Liabilities

Latest as of June 2025: AU$1.04 Million AUD ≈ $735.36K USD

Based on the latest financial reports, Vectus Biosystems Ltd (VBS) has total liabilities worth AU$1.04 Million AUD (≈ $735.36K USD) as of June 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Also explore VBS net assets growth trend to track the company's year-over-year net asset growth rate.

Vectus Biosystems Ltd - Total Liabilities Trend (2012–2025)

This chart illustrates how Vectus Biosystems Ltd's total liabilities have evolved over time, based on quarterly financial data.

Vectus Biosystems Ltd Competitors by Total Liabilities

The table below lists competitors of Vectus Biosystems Ltd ranked by their total liabilities.

Company	Country	Total Liabilities
Lycaon Resources Ltd AU:LYN	Australia	AU$97.12K
Aptevo Therapeutics Inc NASDAQ:APVO	USA	$8.29 Million
Tarena International Inc NASDAQ:TCTM	USA	$1.90 Billion
Hansa Investment Company Ltd LSE:HANA	UK	GBX513.00K
Permaju Industries Bhd KLSE:7080	Malaysia	RM30.93 Million
Newton Golf Company NASDAQ:NWTG	USA	$2.37 Million
Noram Lithium Corp V:NRM	Canada	CA$1.19 Million
TENET FINTECH GROUP INC. F:P0T	Germany	€29.27 Million

Liability Composition Analysis (2012–2025)

This chart breaks down Vectus Biosystems Ltd's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see VBS stock market capitalisation.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric	Value	Description
Current Ratio	0.93	Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio	N/A	More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio	N/A	Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity	-4.05	Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets	1.33	Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Vectus Biosystems Ltd's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Vectus Biosystems Ltd (2012–2025)

The table below shows the annual total liabilities of Vectus Biosystems Ltd from 2012 to 2025.

Year	Total Liabilities	Change
2025-06-30	AU$1.04 Million ≈ $735.36K	+92.72%
2024-06-30	AU$539.26K ≈ $381.56K	-51.26%
2023-06-30	AU$1.11 Million ≈ $782.91K	-86.76%
2022-06-30	AU$8.36 Million ≈ $5.91 Million	-15.39%
2021-06-30	AU$9.88 Million ≈ $6.99 Million	+1.75%
2020-06-30	AU$9.71 Million ≈ $6.87 Million	+147.42%
2019-06-30	AU$3.92 Million ≈ $2.78 Million	+59.99%
2018-06-30	AU$2.45 Million ≈ $1.74 Million	+306.08%
2017-06-30	AU$603.99K ≈ $427.36K	-35.45%
2016-06-30	AU$935.75K ≈ $662.10K	+83.27%
2015-06-30	AU$510.57K ≈ $361.26K	-22.93%
2014-06-30	AU$662.45K ≈ $468.73K	+28.40%
2013-06-30	AU$515.93K ≈ $365.06K	-56.18%
2012-06-30	AU$1.18 Million ≈ $833.07K	--

About Vectus Biosystems Ltd

AU:VBS Australia Biotechnology

Market Cap

$4.91 Million

AU$6.95 Million AUD

Market Cap Rank

#28581 Global

#1524 in Australia

Share Price

AU$0.13

Change (1 day)

+0.00%

52-Week Range

AU$0.05 - AU$0.44

All Time High

AU$2.00